Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Max Healthcare Institute Ltd.
Source DateBoard Meeting DateDetails
06-Aug-2025 13-Aug-2025 Quarterly Results
13-May-2025 20-May-2025 Final Dividend & Audited Results
24-Jan-2025 30-Jan-2025 Quarterly Results
30-Oct-2024 05-Nov-2024 Quarterly Results
24-Jul-2024 01-Aug-2024 Quarterly Results
16-May-2024 22-May-2024 Final Dividend & Audited Results
20-Jan-2024 31-Jan-2024 Quarterly Results
27-Oct-2023 06-Nov-2023 Quarterly Results
28-Jul-2023 07-Aug-2023 Quarterly Results
10-May-2023 16-May-2023 Final Dividend & Audited Results
25-Jan-2023 02-Feb-2023 Quarterly Results & Inter alia, to consider and approve Proposal for Issue of Non-Convertible Debentures
21-Oct-2022 01-Nov-2022 Quarterly Results
27-Jul-2022 10-Aug-2022 Quarterly Results
18-May-2022 25-May-2022 Audited Results
02-Feb-2022 12-Feb-2022 Quarterly Results
01-Nov-2021 12-Nov-2021 Quarterly Results
02-Aug-2021 10-Aug-2021 Quarterly Results
20-May-2021 28-May-2021 Audited Results
27-Jan-2021 06-Feb-2021 Quarterly Results
30-Oct-2020 11-Nov-2020 Quarterly Results
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.